Related Experiment Video

Updated: Oct 17, 2026

Assessing Cellular Target Engagement by SHP2 (PTPN11) Phosphatase Inhibitors
08:45

Assessing Cellular Target Engagement by SHP2 (PTPN11) Phosphatase Inhibitors

Published on: July 17, 2020

Evidence for regulation of the PTEN tumor suppressor by a membrane-localized multi-PDZ domain containing scaffold

X Wu1, K Hepner, S Castelino-Prabhu

  • 1Department of Medicine, Molecular Biology Institute, University of California, Los Angeles, CA 90095, USA.

Proceedings of the National Academy of Sciences of the United States of America
|April 13, 2000
PubMed

Insights

The protein MAGI-2 (membrane associated guanylate kinase inverted-2) binds to the tumor suppressor PTEN, enhancing its cancer-fighting activity. This interaction stabilizes PTEN and improves its signaling at the cell membrane.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Cancer Research

Background:

  • PTEN is a critical tumor suppressor gene frequently mutated in human cancers.
  • Mutations in PTEN can affect its C-terminal PDZ-binding motif, impacting protein function and stability.
  • Understanding PTEN interactions is crucial for developing targeted cancer therapies.

Purpose of the Study:

  • To identify novel PTEN-interacting proteins.
  • To investigate the role of MAGI-2 in PTEN signaling and tumor suppression.
  • To explore how MAGI-2 affects PTEN stability and function.

Main Methods:

  • Yeast two-hybrid screening to identify PTEN-interacting proteins.
  • Immunofluorescence and cell fractionation to determine MAGI-2 localization.
  • Co-immunoprecipitation assays to confirm PTEN-MAGI-2 interaction.
  • Analysis of Akt activation and PTEN protein stability in response to MAGI-2.

Main Results:

  • MAGI-2, a membrane-associated guanylate kinase with multiple PDZ domains, was identified as a PTEN-binding partner.
  • MAGI-2 localizes to tight junctions in epithelial cells and binds PTEN via its PDZ domain.
  • MAGI-2 enhances PTEN's ability to suppress Akt activation.
  • Restoring the PDZ-binding motif to truncated PTEN mutants stabilizes the protein, an effect enhanced by MAGI-2.

Conclusions:

  • MAGI-2 acts as a scaffold protein, improving PTEN signaling efficiency by forming a multiprotein complex at the cell membrane.
  • MAGI-2 interaction stabilizes PTEN, potentially counteracting the effects of cancer-associated mutations.
  • Targeting the PTEN-MAGI-2 interaction could offer a novel therapeutic strategy for PTEN-deficient cancers.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Assembly of Signaling Complexes01:30

Assembly of Signaling Complexes

Multiprotein signaling complexes are formed in a dynamic process involving protein-protein interactions at the cytoplasmic domain of transmembrane receptors or enzymatic and non-enzymatic proteins associated with the receptor. These complexes ensure the activation and propagation of intracellular signals that regulate cell functions.
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...